DNA SEQ 2, INC. — Form D
DNA SEQ 2, INC. of VISTA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-11. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-03-11
- Form: D
- Accession: 0002115201-26-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.2M
- Investors: 32
- Date of first sale: 2024-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576158
Issuer
- Name: DNA SEQ 2, INC.
- CIK: 0002115201
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1255 E VISTA WAY #157, VISTA, CA, 92084
- Phone: 585-987-2800
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Benjamin M. Anderson | Director | Vista, CA |
| Eric Maria Ladizinsky | Director | Vista, CA |
| Stuart E. Siegel | Director | Vista, CA |
| Janusz Maria Sowadski | Director | Vista, CA |
| Thomas M. Wheeler | Director | Vista, CA |
| Andrew Nappin | Executive Officer | Vista, CA |
More